192 related articles for article (PubMed ID: 16455109)
41. Expression and function of efflux drug transporters in the intestine.
Takano M; Yumoto R; Murakami T
Pharmacol Ther; 2006 Jan; 109(1-2):137-61. PubMed ID: 16209890
[TBL] [Abstract][Full Text] [Related]
42. Aristolochic acid I is a substrate of BCRP but not P-glycoprotein or MRP2.
Ma L; Qin Y; Shen Z; Bi H; Hu H; Huang M; Zhou H; Yu L; Jiang H; Zeng S
J Ethnopharmacol; 2015 Aug; 172():430-5. PubMed ID: 26183576
[TBL] [Abstract][Full Text] [Related]
43. Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP).
Pick A; Müller H; Mayer R; Haenisch B; Pajeva IK; Weigt M; Bönisch H; Müller CE; Wiese M
Bioorg Med Chem; 2011 Mar; 19(6):2090-102. PubMed ID: 21354800
[TBL] [Abstract][Full Text] [Related]
44. Understanding the Composition, Biosynthesis, Accumulation and Transport of Flavonoids in Crops for the Promotion of Crops as Healthy Sources of Flavonoids for Human Consumption.
Ku YS; Ng MS; Cheng SS; Lo AW; Xiao Z; Shin TS; Chung G; Lam HM
Nutrients; 2020 Jun; 12(6):. PubMed ID: 32521660
[TBL] [Abstract][Full Text] [Related]
45. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
46. Transport of glyburide by placental ABC transporters: implications in fetal drug exposure.
Gedeon C; Behravan J; Koren G; Piquette-Miller M
Placenta; 2006; 27(11-12):1096-102. PubMed ID: 16460798
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of the binding of the tricyclic isoxazole photoaffinity label LY475776 to multidrug resistance associated protein 1 (MRP1) orthologs and several ATP- binding cassette (ABC) drug transporters.
Dantzig AH; Shepard RL; Pratt SE; Tabas LB; Lander PA; Ma L; Paul DC; Williams DC; Peng SB; Slapak CA; Godinot N; Perry WL
Biochem Pharmacol; 2004 Mar; 67(6):1111-21. PubMed ID: 15006547
[TBL] [Abstract][Full Text] [Related]
48. Which sources of flavonoids: complex diets or dietary supplements?
Egert S; Rimbach G
Adv Nutr; 2011 Jan; 2(1):8-14. PubMed ID: 22211185
[TBL] [Abstract][Full Text] [Related]
49. Metabolism and transport of the citrus flavonoid hesperetin in Caco-2 cell monolayers.
Brand W; van der Wel PA; Rein MJ; Barron D; Williamson G; van Bladeren PJ; Rietjens IM
Drug Metab Dispos; 2008 Sep; 36(9):1794-802. PubMed ID: 18515333
[TBL] [Abstract][Full Text] [Related]
50. Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties.
Galati G; O'Brien PJ
Free Radic Biol Med; 2004 Aug; 37(3):287-303. PubMed ID: 15223063
[TBL] [Abstract][Full Text] [Related]
51. Transport of diclofenac by breast cancer resistance protein (ABCG2) and stimulation of multidrug resistance protein 2 (ABCC2)-mediated drug transport by diclofenac and benzbromarone.
Lagas JS; van der Kruijssen CM; van de Wetering K; Beijnen JH; Schinkel AH
Drug Metab Dispos; 2009 Jan; 37(1):129-36. PubMed ID: 18845662
[TBL] [Abstract][Full Text] [Related]
52. Characterization of chrysin glucuronidation in UGT1A1-overexpressing HeLa cells: elucidating the transporters responsible for efflux of glucuronide.
Quan E; Wang H; Dong D; Zhang X; Wu B
Drug Metab Dispos; 2015 Apr; 43(4):433-43. PubMed ID: 25595598
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of ABCG2/BCRP transporter by soy isoflavones genistein and daidzein: effect on plasma and milk levels of danofloxacin in sheep.
Perez M; Otero JA; Barrera B; Prieto JG; Merino G; Alvarez AI
Vet J; 2013 May; 196(2):203-8. PubMed ID: 23083838
[TBL] [Abstract][Full Text] [Related]
54. Regulation of expression and activity of multidrug resistance proteins MRP2 and MDR1 by estrogenic compounds in Caco-2 cells. Role in prevention of xenobiotic-induced cytotoxicity.
Arias A; Rigalli JP; Villanueva SS; Ruiz ML; Luquita MG; Perdomo VG; Vore M; Catania VA; Mottino AD
Toxicology; 2014 Jun; 320():46-55. PubMed ID: 24685904
[TBL] [Abstract][Full Text] [Related]
55. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade.
Chen Z; Shi T; Zhang L; Zhu P; Deng M; Huang C; Hu T; Jiang L; Li J
Cancer Lett; 2016 Jan; 370(1):153-64. PubMed ID: 26499806
[TBL] [Abstract][Full Text] [Related]
56. Potential role of ATP-binding cassette transporters in the intestinal transport of rhein.
Ye L; Lu L; Li Y; Zeng S; Yang X; Chen W; Feng Q; Liu W; Tang L; Liu Z
Food Chem Toxicol; 2013 Aug; 58():301-5. PubMed ID: 23665409
[TBL] [Abstract][Full Text] [Related]
57. Role of P-glycoprotein in the intestinal absorption of glabridin, an active flavonoid from the root of Glycyrrhiza glabra.
Cao J; Chen X; Liang J; Yu XQ; Xu AL; Chan E; Wei D; Huang M; Wen JY; Yu XY; Li XT; Sheu FS; Zhou SF
Drug Metab Dispos; 2007 Apr; 35(4):539-53. PubMed ID: 17220245
[TBL] [Abstract][Full Text] [Related]
58. The interactions of lenalidomide with human uptake and efflux transporters and UDP-glucuronosyltransferase 1A1: lack of potential for drug-drug interactions.
Tong Z; Yerramilli U; Surapaneni S; Kumar G
Cancer Chemother Pharmacol; 2014 Apr; 73(4):869-74. PubMed ID: 24627218
[TBL] [Abstract][Full Text] [Related]
59. The potential of flavonoids to influence drug metabolism and pharmacokinetics by local gastrointestinal mechanisms.
Cermak R; Wolffram S
Curr Drug Metab; 2006 Oct; 7(7):729-44. PubMed ID: 17073577
[TBL] [Abstract][Full Text] [Related]
60. Application and limitation of inhibitors in drug-transporter interactions studies.
Wang Q; Strab R; Kardos P; Ferguson C; Li J; Owen A; Hidalgo IJ
Int J Pharm; 2008 May; 356(1-2):12-8. PubMed ID: 18272304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
